Diabetes News from ScienceDaily

29 May 2023

Learn about early diabetes symptoms, diabetic diet information, diabetes care, type 1 diabetes, insulin resistance and type 2 diabetes. Read the latest medical research on diabetes.
  • Scientists target human stomach cells for diabetes therapy
    Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a preclinical study.
  • Experimental drug inhibits or prevents diabetic eye disease
    Researchers say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.
  • Afternoon exercise linked with greater improvements in blood sugar levels for patients with type 2 diabetes
    A new study uses data from the Look AHEAD (Action for Health in Diabetes) study, a randomized controlled trial that compared an intensive lifestyle intervention with diabetes support and education in patients diagnosed with type 2 diabetes and overweight or obesity to track the development of cardiovascular disease over time.
  • Researchers map the brain during blood sugar changes
    Researchers have successfully mapped specific regions in the brain that are activated in association with changes in blood sugar -- also known as glucose -- providing fundamental location information that could ultimately lead to more targeted therapies for people who struggle with conditions like diabetes.
  • Artificial pancreas reduces disease management burden for people with diabetes
    Researchers design a novel algorithm for controlling implanted insulin pumps that accounts for the unique characteristics of individual patients. Their model, tested using an FDA-approved diabetes computer simulation, proves intraperitoneal (within the abdominal cavity) insulin delivery is fast and closely mimics natural physiological insulin delivery. They developed a model that can account for individual patient differences and validated a pump control algorithm that does not require meal announcement.